Search

everythinglearnresearchcommunity

for

Search:↓

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

The patient has frontal fibrosing alopecia (FFA).

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Early treatment helps stop hair loss in women of color.

Backhousia citriodora leaf extract effectively reduces oily skin across different ethnic groups.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

The new scalp treatment preserves hair color, reduces hair loss, and maintains hair strength.

Stabilizing HIF-1A in hair follicles may reduce oxidative stress and promote hair growth by increasing glycolysis.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.